The Centers for Disease Control and Prevention (CDC) recommends using nucleic-acid amplification tests (NAAT) when testing female patients under the age of 25 for Chlamydia trachomatis.
Although the Centers for Disease Control and Prevention (CDC) recommends using nucleic-acid amplification tests (NAAT), many clinicians still use urine NAAT to test for Chlamydia trachomatis in sexually active female patients under the age of 25.
A new report explored whether an improvement program could be beneficial in increasing the number of clinicians using the vaginal swab NAAT. The study ultimately discovered that the quality improvement program did, in fact, lead to significant increase in the use of vaginal swabs to test for C. trachomatis.
For details on this study and its findings, visit Contemporary Pediatrics.
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Postmenopausal urinary incontinence treatment data found lacking
May 6th 2024Discover the findings of a comprehensive study exploring the efficacy of various treatments for postmenopausal urinary incontinence, shedding light on the current research gap and recommending avenues for future investigation.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More